{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:20:01Z","timestamp":1793751601624,"version":"4.6.1"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.psychres.2023.115357","type":"journal-article","created":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T13:41:42Z","timestamp":1690119702000},"page":"115357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Pharmacotherapy compared to placebo for people with Bulimia Nervosa: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"327","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2152-161X","authenticated-orcid":false,"given":"Aikaterini","family":"Argyrou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7978-6496","authenticated-orcid":false,"given":"Andreas S.","family":"Lappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra Rafailia","family":"Bakaloudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Tsekitsidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissavet","family":"Mathioudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Michou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2312-6728","authenticated-orcid":false,"given":"Zoi","family":"Polyzopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6401-0828","authenticated-orcid":false,"given":"Nikos","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Papazisis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9490-8356","authenticated-orcid":false,"given":"Michail","family":"Chourdakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-5091","authenticated-orcid":false,"given":"Myrto T.","family":"Samara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psychres.2023.115357_bib0049","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/1098-108X(198701)6:1<29::AID-EAT2260060105>3.0.CO;2-2","article-title":"Imipramine in the treatment of bulimia: a double-blind controlled study","volume":"6","author":"Agras","year":"1987","journal-title":"Int. J. Eat. Disord."},{"issue":"6","key":"10.1016\/j.psychres.2023.115357_bib0051","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/15622975.2011.602720","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders","volume":"12","author":"Aigner","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2023.115357_bib0052","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","article-title":"Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability","volume":"58","author":"Anderson","year":"2000","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2023.115357_bib0093","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/02813432.2011.595582","article-title":"General practitioners\u2019 experiences using cognitive behavioural therapy in general practice: a qualitative study","volume":"29","author":"Aschim","year":"2011","journal-title":"Scand. J. Prim. Health Care"},{"issue":"2","key":"10.1016\/j.psychres.2023.115357_bib0021","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/j.1440-1614.2000.00709.x","article-title":"Antidepressants versus placebo for the treatment of bulimia nervosa: a systematic review","volume":"34","author":"Bacaltchuk","year":"2000","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115357_bib0034","doi-asserted-by":"crossref","unstructured":"Baker JH, Girdler SS, Bulik CM. The role of reproductive hormones in the development and maintenance of eating disorders. 101586\/eog1254. 2014;7(6):573\u2013583. doi:10.1586\/EOG.12.54.","DOI":"10.1586\/eog.12.54"},{"issue":"7","key":"10.1016\/j.psychres.2023.115357_bib0075","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1176\/ps.50.7.945","article-title":"A survey of prescribing practices for monoamine oxidase inhibitors","volume":"50","author":"Balon","year":"1999","journal-title":"Psychiatr. Serv."},{"issue":"2 CC\u2013Common Mental Disorders","key":"10.1016\/j.psychres.2023.115357_bib0047","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/070674378803300211","article-title":"Treatment of bulimia with desipramine: a double-blind crossover study","volume":"33","author":"Barlow","year":"1988","journal-title":"Can. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2023.115357_bib0048","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/070674378803300211","article-title":"Treatment of bulimia with desipramine: a double-blind crossover study","volume":"33","author":"Barlow","year":"1988","journal-title":"Can. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2023.115357_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14740338.2018.1395854","article-title":"Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder","volume":"17","author":"Bello","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"issue":"7","key":"10.1016\/j.psychres.2023.115357_bib0067","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00002018-200124070-00004","article-title":"Behavioural effects of the new anticonvulsants","volume":"24","author":"Besag","year":"2001","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.psychres.2023.115357_bib0061","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/ajad.12858","article-title":"Impulsiveness as a predictor of topiramate response for cocaine use disorder","volume":"28","author":"Blevins","year":"2019","journal-title":"Am. J. Addict."},{"issue":"6","key":"10.1016\/j.psychres.2023.115357_bib0033","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jrp.2012.08.001","article-title":"Daily fluctuations in perfectionism dimensions and their relation to eating disorder symptoms","volume":"46","author":"Boone","year":"2012","journal-title":"J. Res. Pers."},{"key":"10.1016\/j.psychres.2023.115357_bib0001","unstructured":"Bulimia Nervosa - StatPearls - NCBI Bookshelf. Accessed July 11, 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562178\/."},{"issue":"4","key":"10.1016\/j.psychres.2023.115357_bib0076","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40501-019-00189-5","article-title":"Current pharmacological treatments for childhood-onset eating disorders","volume":"6","author":"Campbell","year":"2019","journal-title":"Curr. Treat. Opt. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2023.115357_bib0068","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004850-200101000-00003","article-title":"Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial","volume":"16","author":"Carruba","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2023.115357_bib0082","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cppeds.2017.02.004","article-title":"Bulimia nervosa\/purging disorder","volume":"47","author":"Castillo","year":"2017","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"issue":"4","key":"10.1016\/j.psychres.2023.115357_bib0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1017\/S1352465813000568","article-title":"Geographic inequity in the availability of cognitive behavioural therapy in England and Wales: a 10-year update","volume":"42","author":"Cavanagh","year":"2014","journal-title":"Behav. Cogn. Psychother."},{"issue":"3","key":"10.1016\/j.psychres.2023.115357_bib0077","first-page":"370","article-title":"The efficacy and safety of the naltrexone\/bupropion combination for the treatment of obesity: an update","volume":"14","author":"Christou","year":"2015","journal-title":"Hormones (Athens)"},{"issue":"1","key":"10.1016\/j.psychres.2023.115357_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40337-015-0080-0","article-title":"Medication and psychotherapy in eating disorders: is there a gap between research and practice?","volume":"3","author":"Cooper","year":"2015","journal-title":"J. Eat. Disord."},{"issue":"2","key":"10.1016\/j.psychres.2023.115357_bib0012","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/appi.ajp.23180001","article-title":"The American psychiatric association practice guideline for the treatment of patients with eating disorders","volume":"180","author":"Crone","year":"2023","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2023.115357_bib0036","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/eat.20496","article-title":"Eating disorder symptoms in pregnancy: a prospective study","volume":"41","author":"Crow","year":"2008","journal-title":"Int. J. Eat. Disord."},{"issue":"2","key":"10.1016\/j.psychres.2023.115357_bib0073","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.psc.2019.01.007","article-title":"Pharmacologic treatment of eating disorders","volume":"42","author":"Crow","year":"2019","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"6","key":"10.1016\/j.psychres.2023.115357_bib0053","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/YCO.0000000000000358","article-title":"Pharmacotherapy of eating disorders","volume":"30","author":"Davis","year":"2017","journal-title":"Curr. Opin. Psychiatry"},{"issue":"7109","key":"10.1016\/j.psychres.2023.115357_bib0042","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2023.115357_bib0043","doi-asserted-by":"crossref","DOI":"10.3310\/hta7010","article-title":"How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study","author":"Egger","year":"2003","journal-title":"Artic. Health Technol. Assess."},{"issue":"4","key":"10.1016\/j.psychres.2023.115357_bib0035","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1891\/0889-8391.27.4.338","article-title":"A condensed dialectical behavior therapy skills group for binge eating disorder: overcoming winter challenges","volume":"27","author":"Erb","year":"2013","journal-title":"J. Cogn. Psychother"},{"issue":"1","key":"10.1016\/j.psychres.2023.115357_bib0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nurt.2006.10.003","article-title":"Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain","volume":"4","author":"Ettinger","year":"2007","journal-title":"Neurother"},{"key":"10.1016\/j.psychres.2023.115357_bib0014","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1992.01820020059008","article-title":"A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group","volume":"49","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2023.115357_bib0009","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/eat.22983","article-title":"A single session assessment and psychoeducational intervention for eating disorders: impact on treatment waitlists and eating disorder symptoms","volume":"51","author":"Fursland","year":"2018","journal-title":"Int. J. Eat. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2023.115357_bib0066","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2005.09.024","article-title":"Adverse psychiatric effects of antiepileptic drugs","volume":"68","author":"Gilliam","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.psychres.2023.115357_bib0024","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0005-7967(97)00041-7","article-title":"A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome","volume":"35","author":"Goldbloom","year":"1997","journal-title":"Behav. Res. Ther."},{"issue":"5","key":"10.1016\/j.psychres.2023.115357_bib0013","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1192\/bjp.166.5.660","article-title":"Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group","volume":"166","author":"Goldstein","year":"1995","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115357_bib0007","unstructured":"Gorla K, Mathews M. Pharmacological treatment of eating disorders. Vol 2. Matrix Medical Communications Accessed January 9, 2021. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3000192\/."},{"key":"10.1016\/j.psychres.2023.115357_bib0078","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.20220267","article-title":"Naltrexone-Bupropion and Behavior Therapy, alone and combined, for binge-eating disorder: randomized double-blind placebo-controlled trial","volume":"179","author":"Grilo","year":"2022","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2023.115357_bib0057","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s40263-015-0244-0","article-title":"Topiramate in alcohol use disorders: review and update","volume":"29","author":"Guglielmo","year":"2015","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.psychres.2023.115357_bib0018","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/eat.22103","article-title":"A systematic review of evidence for psychological treatments in eating disorders: 2005-2012","volume":"46","author":"Hay","year":"2013","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.psychres.2023.115357_bib0031","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/9780470712184.ch8","article-title":"Assessing risk of bias in included studies","author":"Higgins","year":"2008","journal-title":"Cochrane Handb. Syst. Rev. Interv. Cochrane B Ser."},{"key":"10.1016\/j.psychres.2023.115357_bib0032","first-page":"1","article-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019","journal-title":"Cochrane Handb. Syst. Rev. Interv."},{"key":"10.1016\/j.psychres.2023.115357_bib0038","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.psychres.2023.115357_bib0029","unstructured":"Higgins JPT, Thomas J, Chandler J, et\u00a0al. Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training. www.training.cochrane.org\/handbook. Published 2022. Accessed April 6, 2023. https:\/\/training.cochrane.org\/handbook."},{"issue":"7 CC\u2013Common Mental Disorders","key":"10.1016\/j.psychres.2023.115357_bib0079","first-page":"262","article-title":"Treatment of bulimia with bupropion: a multicenter controlled trial","volume":"49","author":"Horne","year":"1988","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2023.115357_bib0041","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archpsyc.1986.01800020092012","article-title":"Treating bulimia with desipramine. A double-blind, placebo-controlled study","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2023.115357_bib0044","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/EDE.0b013e31818131e7","article-title":"Why most discovered true associations are inflated","volume":"19","author":"Ioannidis","year":"2008","journal-title":"Epidemiology"},{"key":"10.1016\/j.psychres.2023.115357_bib0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/erv.452","article-title":"Cognitive-behavioural, fluoxetine and combined treatment for bulimia nervosa: short- and long-term results","volume":"10","author":"Jacobi","year":"2002","journal-title":"Eur. Eat. Disord. Rev."},{"issue":"3","key":"10.1016\/j.psychres.2023.115357_bib0006","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/eat.22670","article-title":"Addressing critical gaps in the treatment of eating disorders","volume":"50","author":"Kazdin","year":"2017","journal-title":"Int. J. Eat. Disord."},{"issue":"11 CC\u2013Common Mental Disorders","key":"10.1016\/j.psychres.2023.115357_bib0069","first-page":"1495","article-title":"Isocarboxazide in the treatment of bulimia","volume":"143","author":"Kennedy","year":"1986","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2023.115357_bib0089","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/eat.22090","article-title":"The research-practice gap: bridging the schism between eating disorder researchers and practitioners","volume":"46","author":"Lilienfeld","year":"2013","journal-title":"Int. J. Eat. Disord."},{"issue":"11","key":"10.1016\/j.psychres.2023.115357_bib0020","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1037\/ccp0000245","article-title":"The efficacy of cognitive-behavioral therapy for eating disorders: a systematic review and meta-analysis","volume":"85","author":"Linardon","year":"2017","journal-title":"J. Consult. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.psychres.2023.115357_bib0054","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.nurpra.2009.02.007","article-title":"Medical management of eating disorders","volume":"5","author":"Mayhew","year":"2009","journal-title":"J. Nurse Pract."},{"issue":"2","key":"10.1016\/j.psychres.2023.115357_bib0059","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.160.2.255","article-title":"Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial","volume":"160","author":"McElroy","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2023.115357_bib0062","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4088\/JCP.v65n1104","article-title":"Topiramate in the long-term treatment of binge-eating disorder associated with obesity","volume":"65","author":"McElroy","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2023.115357_bib0081","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-015-0573-1","article-title":"Psychopharmacologic treatment of eating disorders: emerging findings","volume":"17","author":"McElroy","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"issue":"1","key":"10.1016\/j.psychres.2023.115357_bib0087","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1874205X01913010022","article-title":"Psychopharmacological options in the multidisciplinary and multidimensional treatment of eating disorders","volume":"13","author":"Milano","year":"2019","journal-title":"Open Neurol. J."},{"key":"10.1016\/j.psychres.2023.115357_bib0039","first-page":"89","article-title":"Treatment of binge eating disorder with sertraline: a randomized controlled trial","volume":"16","author":"Milano","year":"2005","journal-title":"Biomed. Res."},{"issue":"3","key":"10.1016\/j.psychres.2023.115357_bib0040","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF02849936","article-title":"Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial","volume":"22","author":"Milano","year":"2005","journal-title":"Adv. Ther."},{"key":"10.1016\/j.psychres.2023.115357_bib0050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004714-198408000-00003","article-title":"A placebo-controlled, double-blind trial of amitriptyline in bulimia","volume":"4","author":"Mitchell","year":"1984","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2023.115357_bib0003","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/eat.20343","article-title":"Treatment of bulimia nervosa: where are we and where are we going?","volume":"40","author":"Mitchell","year":"2007","journal-title":"Int. J. Eat. Disord."},{"issue":"7","key":"10.1016\/j.psychres.2023.115357_bib0064","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00002018-200730070-00001","article-title":"Negative effects of antiepileptic drugs on mood in patients with epilepsy","volume":"30","author":"Mula","year":"2007","journal-title":"Drug Saf."},{"issue":"5","key":"10.1016\/j.psychres.2023.115357_bib0063","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1528-1167.2008.01799.x","article-title":"The role of titration schedule of topiramate for the development of depression in patients with epilepsy","volume":"50","author":"Mula","year":"2009","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.psychres.2023.115357_bib0083","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1017\/S1092852921000365","article-title":"Bupropion-myth-busting!","volume":"27","author":"Naguy","year":"2022","journal-title":"CNS Spectr."},{"issue":"4","key":"10.1016\/j.psychres.2023.115357_bib0022","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10673220216226","article-title":"A multidimensional meta-analysis of pharmacotherapy for bulimia nervosa: summarizing the range of outcomes in controlled clinical trials","volume":"10","author":"Nakash-Eisikovits","year":"2002","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115357_bib0080","unstructured":"NCT03539900. Efficacy and mechanisms of naltrexone+bupropion for binge eating disorder. https:\/\/clinicaltrials.gov\/show\/NCT03539900. Published online 2018. https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-01659922\/full."},{"issue":"5","key":"10.1016\/j.psychres.2023.115357_bib0058","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1017\/S1092852920001613","article-title":"Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis","volume":"26","author":"Nourredine","year":"2021","journal-title":"CNS Spectr."},{"issue":"2","key":"10.1016\/j.psychres.2023.115357_bib0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40263-020-00780-y","article-title":"Use of topiramate in the spectrum of addictive and eating disorders: a systematic review comparing treatment schemes, efficacy, and safety features","volume":"35","author":"Nourredine","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2023.115357_bib0004","unstructured":"Overview | Eating disorders: recognition and treatment | Guidance | NICE. Accessed December 2, 2021. https:\/\/www.nice.org.uk\/guidance\/ng69."},{"key":"10.1016\/j.psychres.2023.115357_bib0046","unstructured":"Overview | Eating disorders: recognition and treatment | Guidance | NICE 2023."},{"key":"10.1016\/j.psychres.2023.115357_bib0091","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1192\/bjp.181.3.230","article-title":"Self-help for bulimic disorders: a randomised controlled trial comparing minimal guidance with face-to-face or telephone guidance","volume":"181","author":"Palmer","year":"2002","journal-title":"Br. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2023.115357_bib0019","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1017\/S0033291713002791","article-title":"Group therapy for people with bulimia nervosa: systematic review and meta-analysis","volume":"44","author":"Polnay","year":"2014","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.psychres.2023.115357_bib0088","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinthera.2020.10.006","article-title":"Psychotherapy and medications for eating disorders: better together?","volume":"43","author":"Reas","year":"2021","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.psychres.2023.115357_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1098-108X(199401)15:1<1::AID-EAT2260150102>3.0.CO;2-E","volume":"15","author":"Rothschild","year":"1994","journal-title":"Int. J. Eat. Disord."},{"issue":"10347","key":"10.1016\/j.psychres.2023.115357_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(22)01322-8","article-title":"What is the right drug for insomnia disorder?","volume":"400","author":"Samara","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.psychres.2023.115357_bib0090","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.brat.2009.07.003","article-title":"Mind the gap: improving the dissemination of CBT","volume":"47","author":"Shafran","year":"2009","journal-title":"Behav. Res. Ther."},{"issue":"8","key":"10.1016\/j.psychres.2023.115357_bib0056","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/add.13328","article-title":"Topiramate for cocaine dependence: a systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Singh","year":"2016","journal-title":"Addiction"},{"issue":"16","key":"10.1016\/j.psychres.2023.115357_bib0015","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1017\/S0033291718001071","article-title":"Treatments for bulimia nervosa: a network meta-analysis","volume":"48","author":"Slade","year":"2018","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.psychres.2023.115357_bib0027","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/YCO.0b013e328365a24f","article-title":"Epidemiology, course, and outcome of eating disorders","volume":"26","author":"Smink","year":"2013","journal-title":"Curr. Opin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2023.115357_bib0074","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1517\/14728214.11.2.315","article-title":"Emerging drugs for eating disorder treatment","volume":"11","author":"Steffen","year":"2006","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"4","key":"10.1016\/j.psychres.2023.115357_bib0084","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-0043-117962","article-title":"Epileptic Seizures under antidepressive drug treatment: systematic review","volume":"51","author":"Steinert","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2023.115357_bib0023","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1017\/S0033291718003525","article-title":"Efficacy of psychotherapies and pharmacotherapies for Bulimia nervosa","volume":"49","author":"Svaldi","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2023.115357_bib0002","article-title":"The economic cost of bulimia nervosa and binge eating disorder: a population-based study","author":"Tannous","year":"2021","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.psychres.2023.115357_bib0008","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000508143","article-title":"Improving Cost-effectiveness and access to cognitive behavior therapy for depression: providing remote-ready, computer-assisted psychotherapy in times of crisis and beyond","volume":"89","author":"Thase","year":"2020","journal-title":"Psychother. Psychosom."},{"issue":"3","key":"10.1016\/j.psychres.2023.115357_bib0017","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/clipsy.bpg024","article-title":"A Multidimensional meta-analysis of psychotherapy for Bulimia Nervosa","volume":"10","author":"Thompson-Brenner","year":"2003","journal-title":"Clin. Psychol. Sci. Pract."},{"issue":"10227","key":"10.1016\/j.psychres.2023.115357_bib0026","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(20)30059-3","article-title":"Eating disorders","volume":"395","author":"Treasure","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.psychres.2023.115357_bib0028","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jclinepi.2004.02.018","article-title":"Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time","volume":"57","author":"Trikalinos","year":"2004","journal-title":"J. Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.psychres.2023.115357_bib0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/eat.20696","article-title":"Meta-analysis of the effectiveness of psychological and pharmacological treatments for binge eating disorder","volume":"43","author":"Vocks","year":"2010","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.psychres.2023.115357_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.invent.2018.02.010","article-title":"Using internet-based self-help to bridge waiting time for face-to-face outpatient treatment for Bulimia Nervosa, Binge Eating Disorder and related disorders: study protocol of a randomized controlled trial","volume":"16","author":"Vollert","year":"2018","journal-title":"Internet Interv."},{"key":"10.1016\/j.psychres.2023.115357_bib0071","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0022-3956(85)90058-5","article-title":"A double-blind trial of phenelzine in bulimia","volume":"19","author":"Walsh","year":"1985","journal-title":"J. Psychiatr. Res."},{"issue":"5 CC\u2013Common Mental Disorders","key":"10.1016\/j.psychres.2023.115357_bib0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.1988.01800290091011","article-title":"Phenelzine vs placebo in 50 patients with bulimia","volume":"45","author":"Walsh","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2023.115357_bib0016","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0005-7894(99)80049-5","article-title":"Bulimia nervosa: a meta-analysis of psychosocial and pharmacological treatments","volume":"30","author":"Whittal","year":"1999","journal-title":"Behav. Ther."},{"issue":"7","key":"10.1016\/j.psychres.2023.115357_bib0094","first-page":"993","article-title":"Using cognitive behavioural therapy in practice: qualitative study of family physicians\u2019 experiences","volume":"51","author":"Wiebe","year":"2005","journal-title":"Can. Fam. Phys."},{"issue":"4","key":"10.1016\/j.psychres.2023.115357_bib0037","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cpr.2012.01.006","article-title":"A review of the definitions of outcome used in the treatment of bulimia nervosa","volume":"32","author":"Williams","year":"2012","journal-title":"Clin. Psychol. Rev."},{"issue":"7644","key":"10.1016\/j.psychres.2023.115357_bib0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.psychres.2023.115357_bib0092","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025031","article-title":"Clinical and cost-effectiveness of one-session treatment (OST) versus multisession cognitive\u2013behavioural therapy (CBT) for specific phobias in children: protocol for a non-inferiority randomised controlled trial","volume":"8","author":"Wright","year":"2018","journal-title":"BMJ Open"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123003074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123003074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T20:26:00Z","timestamp":1717619160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178123003074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":93,"alternative-id":["S0165178123003074"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115357","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapy compared to placebo for people with Bulimia Nervosa: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115357"}}